ELAN
Elanco Animal Health Inc
+0.34 (+1.51%)23.21USD1.5M成交股數11.6B市值–本益比(近四季)2.3股價營收比+10.2%營收年增(近四季)2026-11-06下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.4B+10% | 1.4B+15% | 1.1B+11% | 1.1B-4% | 1.2B+3% | 1.2B+15% | 1.0B-4% | 1.2B+12% | 1.2B | 1.0B | 1.1B | 1.1B |
| 營業成本 | 570M | 586M | 555M | 530M | 528M | 509M | 492M | 495M | 515M | 516M | 487M | 434M |
| 毛利 | 798M+12% | 785M+15% | 589M+9% | 607M-12% | 713M+3% | 684M+32% | 538M-7% | 689M+11% | 690M | 519M | 581M | 623M |
| 毛利率 | 58.3% | 57.3% | 51.5% | 53.4% | 57.5% | 57.3% | 52.2% | 58.2% | 57.3% | 50.1% | 54.4% | 58.9% |
| 研發費用 | 92.0M | 97.0M | 93.0M | 89.0M | 92.0M | 94.0M | 87.0M | 89.0M | 87.0M | 79.0M | 86.0M | 81.0M |
| 銷售管理費用 | 449M | 381M | 338M | 351M | 400M | 341M | 323M | 354M | 337M | 292M | 313M | 353M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 54.0M+391% | 57.0M-15% | −276M-176% | −34.0M-32% | 11.0M-66% | 67.0M-148% | 364M-133% | −50.0M-48% | 32.0M | −141M | −1.1B | −97.0M |
| 淨利率 | 3.9% | 4.2% | -24.1% | -3.0% | 0.9% | 5.6% | 35.3% | -4.2% | 2.7% | -13.6% | -102.6% | -9.2% |
| 稀釋 EPS | 0.11+450% | 0.11-15% | -0.55-175% | -0.07-30% | 0.02-67% | 0.13-145% | 0.73-133% | -0.10-50% | 0.06 | -0.29 | -2.22 | -0.20 |
| 稀釋股數 | 506M | 506M | 496M | 497M | 500M | 499M | 498M | 494M | 496M | 492M | 493M | 493M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 530M | 428M | 545M | 505M | 539M | 487M | 490M | 416M | 345M | 352M | 369M | 367M |
| 應收帳款 | 1.1B | 1.1B | 873M | 894M | 989M | 970M | 840M | 999M | 988M | 842M | 911M | 1.0B |
| 存貨 | 1.8B | 1.7B | 1.7B | 1.7B | 1.7B | 1.6B | 1.6B | 1.6B | 1.6B | 1.7B | 1.7B | 1.7B |
| 總資產 | 13.6B | 13.2B | 13.4B | 13.6B | 13.7B | 12.9B | 13.3B | 13.8B | 14.0B | 14.4B | 14.3B | 15.8B |
| 有息負債 | 3.7B | 3.7B | 3.8B | 3.8B | 4.0B | 4.4B | 4.3B | 5.5B | 5.7B | 5.7B | 5.9B | 6.0B |
| 總負債 | 7.0B | 6.7B | 6.8B | 6.8B | 7.0B | 6.6B | 6.8B | 7.8B | 8.0B | 8.1B | 8.2B | 8.4B |
| 股東權益 | 6.6B | 6.5B | 6.5B | 6.7B | 6.8B | 6.4B | 6.5B | 5.9B | 6.1B | 6.2B | 6.1B | 7.4B |
| 負債比 | 51.4% | 50.8% | 51.0% | 50.2% | 50.7% | 50.9% | 50.9% | 56.8% | 56.8% | 56.7% | 57.2% | 53.0% |
| 淨現金(現金 − 有息負債) | −3.1B | −3.3B | −3.2B | −3.3B | −3.4B | −3.9B | −3.8B | −5.0B | −5.4B | −5.4B | −5.5B | −5.7B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 13.0M-425% | – | – | – | −4.0M | – | – | 2.0M | – | – | – |
| 資本支出 | – | 51.0M | – | – | – | 65.0M | – | – | 24.0M | – | – | – |
| 自由現金流 | – | −38.0M-45% | – | – | – | −69.0M | – | – | −22.0M | – | – | – |
| 折舊攤銷 | – | 172M | – | – | – | 161M | – | – | 166M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -2.8% | – | – | – | -5.8% | – | – | -1.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 4.7B
| Reportable | 4.7B | 100.0% | +6.2% |
|---|
地區2025 年度 · 4.7B
| 美國以外 | 2.5B | 52.6% | +3.2% |
|---|---|---|---|
| 美國 | 2.2B | 47.4% | +9.7% |
產品／服務2025 年度 · 4.7B
| Pet Health | 2.3B | 48.8% | +7.3% |
|---|---|---|---|
| Cattle | 1.1B | 23.9% | +11.7% |
| Poultry | 858M | 18.2% | +7.8% |
| Swine | 379M | 8.0% | +3.6% |
| Contract Manufacturing | 53.0M | 1.1% | +15.2% |
| Farm Animal 小計 | 2.4B | 50.1% | +5.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.7B | +6.2% | −232M | -4.9% | -0.47 | 284M |
| FY2024 | 4.4B | +0.5% | 338M | 7.6% | 0.68 | 394M |
| FY2023 | 4.4B | +0.1% | −1.2B | -27.9% | -2.50 | 131M |
| FY2022 | 4.4B | -7.4% | −78.0M | -1.8% | -0.16 | 281M |
| FY2021 | 4.8B | +45.6% | −483M | -10.1% | -0.99 | 324M |
| FY2020 | 3.3B | +6.6% | −574M | -17.5% | -1.30 | −176M |
| FY2019 | 3.1B | +0.1% | 68.0M | 2.2% | 0.18 | 84.0M |
| FY2018 | 3.1B | – | 86.5M | 2.8% | 0.28 | 353M |